| Study Group |
| MR in Drug Research |
| Chair: Patricia E. Cole,
M.D., Ph.D., Eisai Pharmaceuticals, Teaneck, NJ, USA |
| |
| Topics: Academic-Industry
Partnerships in Applications of MRI to Clinical Drug
Development |
| |
| Monday, 20 April 2009 |
| 18:30 - 20:30 |
| Room 312 |
|
| |
| Overview: Matching MRI
Applications to Goals of Drug Development |
| Perry Renshaw, M.D., Ph.D.,
University of Utah, UT, USA |
| |
| Finding Value for MRI in
Supporting a Drug Pipeline: a View from Industry |
| Rexford Newbould, Ph.D.,
GlaxoSmithKline Clinical Imaging Centre, London, UK |
| |
|
Analysis Tools for
Quantitative MRI Supporting Clinical Applications
|
|
Stephen M. Smith, D.Phil.,
Centre for Functional Magnetic Resonance Imaging,
University of Oxford, Oxford, UK
|
|
|
| Practical Considerations
for an Academic Laboratory Working to Support Pharma
Industry Projects: Demystifying Some of the "Unknown
Unknowns" |
| Nicola De Stefano, M.D.,
Ph.D., University of Siena, Siena, Italy |
|
|
|
|